Relationship Between the Occurrence of Depression and DROSHA (rs6877842, rs10719) and XPO5 (rs11077) Single-Nucleotide Polymorphisms in the Polish Population: A Case–Control Study
Authors:
- Mateusz KowalczykMKMateusz Kowalczyk
- Edward KowalczykEKEdward Kowalczyk
- Monika TalarowskaMonika Talarowska
- Ireneusz MajsterekIMIreneusz Majsterek
- Maciej SkrzypekMSMaciej Skrzypek
- Tomasz PopławskiTPTomasz Popławski
- Monika SienkiewiczMSMonika Sienkiewicz
- Anna Wiktorowska-OwczarekAWAnna Wiktorowska-Owczarek
- Paulina SokołowskaPSPaulina Sokołowska
- Marta Jóźwiak-BębenistaMarta Jóźwiak-Bębenista
Open Access
- 14 November 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (22) , 12204
Abstract
Although the epidemiology and symptoms of major depressive disorder (MDD) have been well-documented, the etiology and pathophysiology of the disease have not yet been fully explained. Depression arises from intricate interplay among social, psychological, and biological factors. Recently, there has been growing focus on the involvement of miRNAs in depression, with suggestions that abnormal miRNA processing locally at the synapse contributes to MDD. Changes in miRNAs may result from altered expression and/or function of the miRNA biogenesis machinery at the synapse. The aim of our research was to assess the relationship between the occurrence of depression and single-nucleotide polymorphisms (SNP) in the following genes in the Polish population: DROSHA (rs6877842; rs10719) and XPO5 (rs11077). This study involved 200 individuals, including 100 with depressive disorders in the study group (SG) and 100 healthy people without MDD in the control group (CG). All participants were unrelated native Caucasian Poles from central Poland. Blood samples were collected to evaluate the single-nucleotide polymorphism of the genes. Findings indicated that within our patient cohort, the risk of depression is increased by polymorphic variants of the rs10719/DROSHA and rs11077/XPO5 genes and lowered by rs6877842/DROSHA. Our study sheds light on the understanding of the genetic basis of depression, which can be used in the rapid diagnosis of this disease.Keywords
Funding Information
- Statutory activity of Medical University of Lodz, Poland (503/1-108-01/503-11-001)
This publication has 31 references indexed in Scilit:
- Association of BMP15 and GDF9 variants to premature ovarian insufficiencyJournal of Assisted Reproduction and Genetics, 2019
- Noncanonical functions of microRNA pathway enzymes – Drosha, DGCR8, Dicer and Ago proteinsFEBS Letters, 2018
- Circulating microRNAs as biomarkers for depression: Many candidates, few finalistsJournal of Affective Disorders, 2018
- Genome-wide Mapping of DROSHA Cleavage Sites on Primary MicroRNAs and Noncanonical SubstratesMolecular Cell, 2017
- MicroRNAs in the Pathobiology and Therapy of AtherosclerosisCanadian Journal of Cardiology, 2017
- Multipotency of Adult Hippocampal NSCs In Vivo Is Restricted by Drosha/NFIBCell Stem Cell, 2016
- Downregulation and tumor-suppressive role of XPO5 in hepatocellular carcinomaMolecular and Cellular Biochemistry, 2016
- Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide TherapyMolecular Therapy Nucleic Acids, 2016
- Determining the role of microRNAs in psychiatric disordersNature Reviews Neuroscience, 2015
- Human RISC Couples MicroRNA Biogenesis and Posttranscriptional Gene SilencingCell, 2005